The time is now for Australia to take definitive steps to promote a thriving Medical Device sector which employs people, creates wealth and improves Australia’s future in a competitive world. CSL’s decision to locate a new plant in Switzerland speaks to the need for the AIM Tax Incentive, which has been clearly shown.
Vestech headlined the Medical Devices Seminar, sponsored by ICN WA, on August 12th, 2014. Attendees from across industry heard from Vestech’s CEO, Dr Greg Roger, as well as Dr Cheryl McRae of the TGA, James Brennan of Design and Industry and Dr Stewart Washer of Cynata Therapuetics.
Removing bureaucratic hurdles, through the JOBS Act in the US, has been shown to directly stimulate commercialisation of innovation.
estech’s CEO, Dr Greg Roger, will be chairing a seminar in Perth August 12 for ICN. This seminar, covering Regulatory Issues and Commercialisation Essentials is a development from the two seminars held in Sydney and Melbourne in MAy and June this year as part of the Federal Government’s Advocate Program.
Following his meetings at BIO Dr Roger was able to meet with the CEO of CONNECT, Greg McKee, to explore collaborations between this US-wide, Californian based innovation network and Australian firms wishing to export to the USA.